![James Brady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Brady
Directeur/Bestuurslid bij
XERIS BIOPHARMA HOLDINGS, INC.
Vermogen: 897 803 $ op 30-06-2026
Profiel
James Brady is an Independent Non-Executive Director at Xeris Biopharma Holdings, Inc. since 2025.
Former roles include Director at Panavance Therapeutics, Inc. from 2021 to 2025, Independent Non-Executive Director at Verona Pharma Ltd. from 2022 to 2025, Chief Financial Officer at MedImmune Ltd. from 2013 to 2018, and Chief Audit Executive at AstraZeneca PLC from 2009 to 2012.
Education includes an MBA from Drexel University and an undergraduate degree from St. Joseph University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2026 | 113.359 ( 0,07% ) | 897 803 $ | 30-06-2026 |
Actieve functies van James Brady
| Bedrijven | Functie | Begin |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Directeur/Bestuurslid | 28-03-2025 |
Eerdere bekende functies van James Brady
| Bedrijven | Functie | Einde |
|---|---|---|
| VERONA PHARMA PLC | Directeur/Bestuurslid | 07-10-2025 |
Panavance Therapeutics, Inc.
 Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur/Bestuurslid | 01-02-2025 |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Financieel Directeur/CFO | 01-01-2018 |
| ASTRAZENECA PLC | Comptroller/Controller/Auditor | 01-01-2012 |
Opleiding van James Brady
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
St. Joseph University
 St. Joseph University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Panavance Therapeutics, Inc.
Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
